'Cures' to cost $106.4bn; exclusivity ups health costs
This article was originally published in Scrip
Executive Summary
The Congressional Budget Office (CBO), a nonpartisan organization that provides budgetary advice to lawmakers, estimated that implementing the 21st Century Cures Act – a bill aimed at overhauling the US biomedical enterprise – would cost $106.4bn over five years, with the reauthorization of the National Institutes of Health (NIH) accounting for most of that amount.